These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

13956 related articles for article (PubMed ID: 1003551)

  • 1. Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines.
    Fidler IJ; Nicolson GL
    J Natl Cancer Inst; 1976 Nov; 57(5):1199-202. PubMed ID: 1003551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor cell and host properties affecting the implantation and survival of blood-borne metastatic variants of B16 melanoma.
    Fidler IJ; Nicolson GL
    Isr J Med Sci; 1978 Jan; 14(1):38-50. PubMed ID: 632082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of organ selectivity in the determination of metastatic patterns of B16 melanoma.
    Hart IR; Fidler IJ
    Cancer Res; 1980 Jul; 40(7):2281-7. PubMed ID: 7388794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological behavior of malignant melanoma cells correlated to their survival in vivo.
    Fidler IJ
    Cancer Res; 1975 Jan; 35(1):218-24. PubMed ID: 1109790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties.
    Irimura T; Gonzalez R; Nicolson GL
    Cancer Res; 1981 Sep; 41(9 Pt 1):3411-8. PubMed ID: 7260906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity.
    Fidler IJ; Gersten DM; Budmen MB
    Cancer Res; 1976 Sep; 36(9 pt.1):3160-5. PubMed ID: 975082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of malignant melanoma variant cell lines for ovary colonization.
    Brunson KW; Nicolson GL
    J Supramol Struct; 1979; 11(4):517-28. PubMed ID: 544929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fate of recirculating B16 melanoma metastatic variant cells in parabiotic syngeneic recipients.
    Fidler IJ; Nicolson GL
    J Natl Cancer Inst; 1977 Jun; 58(6):1867-72. PubMed ID: 864765
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of mouse melanoma cell lines by their mortal malignancy using an experimental metastatic model.
    Nakamura K; Yoshikawa N; Yamaguchi Y; Kagota S; Shinozuka K; Kunitomo M
    Life Sci; 2002 Jan; 70(7):791-8. PubMed ID: 11833741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tertiary amine local anesthetics on the blood-borne implantation and cell surface properties of metastatic mouse melanoma cells.
    Nicolson GL; Fidler IJ; Poste G
    J Natl Cancer Inst; 1986 Mar; 76(3):511-9. PubMed ID: 3456465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma cells selected for adhesion to laminin peptides have different malignant properties.
    Yamamura K; Kibbey MC; Kleinman HK
    Cancer Res; 1993 Jan; 53(2):423-8. PubMed ID: 8417834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials.
    LeGrue SJ; Hearn DR
    Cancer Res; 1983 Nov; 43(11):5106-11. PubMed ID: 6616449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in cytotoxic effects of activated murine peritoneal macrophages and J774 monocytic cells on metastatic variants of B16 melanoma.
    Miner KM; Klostergaard J; Granger GA; Nicolson GL
    J Natl Cancer Inst; 1983 Apr; 70(4):717-24. PubMed ID: 6339778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine melanoma: a model for intracranial metastasis.
    Raz A; Hart IR
    Br J Cancer; 1980 Aug; 42(2):331-41. PubMed ID: 7426339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of phenotypic diversity in the B16 mouse melanoma relative to spontaneous metastasis.
    Stackpole CW
    Cancer Res; 1983 Jul; 43(7):3057-65. PubMed ID: 6850615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of B16 melanoma lung colonization by syngeneic monoclonal antibodies.
    Herd ZL
    Cancer Res; 1987 May; 47(10):2696-703. PubMed ID: 3552203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth in an organ microenvironment as a selective process in metastasis.
    Price JE; Naito S; Fidler IJ
    Clin Exp Metastasis; 1988; 6(1):91-102. PubMed ID: 2961497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in cell density associated with differences in lung-colonizing ability of B16 melanoma cells.
    Baniyash M; Netanel T; Witz IP
    Cancer Res; 1981 Feb; 41(2):433-7. PubMed ID: 7448787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
    Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
    Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of membrane anionic sites on B16 melanoma variants with differing lung colonising potential.
    Raz A; Bucana C; McLellan W; Fidler IJ
    Nature; 1980 Mar; 284(5754):363-4. PubMed ID: 7360272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 698.